{"id":428,"date":"2023-08-25T14:38:39","date_gmt":"2023-08-25T06:38:39","guid":{"rendered":"https:\/\/consulting-hmk.com\/?p=428"},"modified":"2024-01-18T09:59:25","modified_gmt":"2024-01-18T01:59:25","slug":"qijiao-tiaojing-granule-approved-for-marketing","status":"publish","type":"post","link":"https:\/\/www.consulting-hmk.com\/fr\/qijiao-tiaojing-granule-approuve-pour-la-commercialisation\/","title":{"rendered":"La commercialisation du granul\u00e9 Qijiao Tiaojing est approuv\u00e9e"},"content":{"rendered":"<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 R\u00e9cemment, la commercialisation du nouveau compos\u00e9 de m\u00e9decine traditionnelle chinoise (MTC) Qijiao Tiaojing Granule de Hunan Anbang Pharmaceutical Co. a \u00e9t\u00e9 approuv\u00e9e par l'Autorit\u00e9 nationale de pharmacovigilance chinoise.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-411 aligncenter\" title=\"La commercialisation du granul\u00e9 Qijiao Tiaojing est approuv\u00e9e\" src=\"https:\/\/consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-300x150.jpg\" alt=\"La commercialisation du granul\u00e9 Qijiao Tiaojing est approuv\u00e9e\" width=\"570\" height=\"285\" srcset=\"https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-300x150.jpg 300w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-1024x512.jpg 1024w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-768x384.jpg 768w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-1536x768.jpg 1536w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_vr-glasses-medical-diagnosis-screen-dna-digital-interface_7436485_121-2048x1024.jpg 2048w\" sizes=\"(max-width: 570px) 100vw, 570px\" \/><\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">Ce m\u00e9dicament est compos\u00e9 de neuf ingr\u00e9dients, dont Radix Astragali, Colla Corii Asini, Radix Codonopsis et Radix Paeoniae Alba, etc. Il a pour effet de nourrir le Qi, de reconstituer le sang, d'arr\u00eater les saignements et de r\u00e9guler la menstruation. Il est indiqu\u00e9 pour traiter les menstruations prolong\u00e9es caus\u00e9es par l'insertion d'un dispositif intra-ut\u00e9rin et la diff\u00e9renciation des syndromes MTC de d\u00e9ficience du Qi et du sang.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">Des essais cliniques multicentriques, randomis\u00e9s, en double aveugle, contr\u00f4l\u00e9s en parall\u00e8le par la MTC ont montr\u00e9 que le taux de gu\u00e9rison et le taux d'am\u00e9lioration \u00e9taient respectivement de 31,82% et 63,64% dans le groupe exp\u00e9rimental, et de 12,00% et 38,00% dans le groupe contr\u00f4l\u00e9, ce qui d\u00e9montre que les diff\u00e9rences entre les groupes sont statistiquement significatives. La mise sur le march\u00e9 du m\u00e9dicament offre une nouvelle option th\u00e9rapeutique aux patients.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>R\u00e9cemment, la commercialisation du nouveau compos\u00e9 de m\u00e9decine traditionnelle chinoise (MTC) Qijiao Tiaojing Granule de Hunan Anbang Pharmaceutical Co. a \u00e9t\u00e9 approuv\u00e9e par l'Autorit\u00e9 nationale de pharmacovigilance chinoise.<\/p>","protected":false},"author":4,"featured_media":429,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[70],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts\/428"}],"collection":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/comments?post=428"}],"version-history":[{"count":0,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts\/428\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/media\/429"}],"wp:attachment":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/media?parent=428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/categories?post=428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/tags?post=428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}